Is Brown-Forman (BF.B) Pricing Look Attractive After Prolonged Share Price Slide

براون فورمان

Brown-Forman Corporation Class B

BF.B

0.00

  • Wondering whether Brown-Forman's share price now reflects a fair deal or an overreaction, especially after a long slide? This article focuses squarely on what you are getting for the price you pay.
  • The stock last closed at US$24.87, with returns of a 12.8% decline over 7 days, 6.9% decline over 30 days, 4.9% decline year to date, 26.2% decline over 1 year, 58.6% decline over 3 years and 63.7% decline over 5 years. This naturally raises questions about how the current valuation stacks up.
  • Recent coverage around Brown-Forman has highlighted ongoing debate about how to value established consumer brands in the current market context and what investors are willing to pay for slower growing but recognizable names. This background helps frame whether the prolonged share price weakness is purely sentiment driven or linked to how the business is being priced compared with alternatives.
  • Based on Simply Wall St's six point valuation framework, Brown-Forman scores a 5 out of 6 valuation score. The sections that follow will walk through the main valuation approaches, before closing with a more rounded way to think about what the stock might be worth.

Approach 1: Brown-Forman Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model takes estimates of the cash Brown-Forman could generate in the future and discounts those cash flows back to today, to translate them into a single present value per share.

Brown-Forman's latest twelve month free cash flow is about $687.2 million. Using a 2 Stage Free Cash Flow to Equity model, analysts supply explicit forecasts for several years, then Simply Wall St extrapolates further cash flows. For example, projected free cash flow for 2028 is $693.3 million, and the model extends estimates out to 2035 with discounted values provided for each year.

Adding all of those discounted cash flows together gives an estimated intrinsic value of about $37.78 per share. Against the recent share price of $24.87, this implies a 34.2% discount, which indicates that Brown-Forman is trading below the DCF assessed value on this set of assumptions.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Brown-Forman is undervalued by 34.2%. Track this in your watchlist or portfolio, or discover 53 more high quality undervalued stocks.

BF.B Discounted Cash Flow as at Apr 2026
BF.B Discounted Cash Flow as at Apr 2026

Approach 2: Brown-Forman Price vs Earnings

For profitable companies like Brown-Forman, the P/E ratio is a commonly used yardstick because it links what you pay per share to the earnings generated per share. Investors usually pay higher P/E multiples when they expect stronger growth or see lower risk, and lower multiples when growth expectations or perceived risk are more muted.

Brown-Forman currently trades on a P/E of 14.14x. That sits below the Beverage industry average P/E of 17.89x and also below the peer group average of 19.42x. On the surface, that points to a lower price tag for each dollar of earnings compared with many listed peers.

Simply Wall St's Fair Ratio for Brown-Forman is 14.39x. This is a proprietary estimate of what a more appropriate multiple could be, given factors such as earnings growth, profit margins, industry, market cap and company specific risks. Because it blends these drivers, the Fair Ratio gives a more tailored reference point than broad industry or peer comparisons alone. When set against the current P/E of 14.14x, the Fair Ratio suggests Brown-Forman's valuation is slightly lower than that tailored level, indicating the shares look modestly undervalued on this metric.

Result: UNDERVALUED

NYSE:BF.B P/E Ratio as at Apr 2026
NYSE:BF.B P/E Ratio as at Apr 2026

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.

Upgrade Your Decision Making: Choose your Brown-Forman Narrative

Earlier it was mentioned that there is an even better way to understand valuation, so Narratives are introduced here as a simple way for you to write the story behind your numbers by linking your view on Brown-Forman’s future revenue, earnings and margins to a financial forecast and a Fair Value that can be compared with today’s price.

On Simply Wall St’s Community page, Narratives are available as an accessible tool used by millions of investors. They allow you to set your own assumptions, see the implied Fair Value, and then decide whether you think the shares look attractive or expensive when set against the current market price.

Because Narratives update automatically when new data such as earnings, news or analyst revisions come in, your story is not static. You can quickly see how fresh information changes the Fair Value you previously felt comfortable with.

For Brown-Forman, one investor might build a cautious Narrative that lines up with a Fair Value around US$21.00, while another might lean into a more optimistic Narrative closer to US$37.00. Comparing each Fair Value to the actual share price can help you decide whether the stock fits your own expectations.

For Brown-Forman however we will make it really easy for you with previews of two leading Brown-Forman Narratives:

Fair Value: US$37.00

Implied discount to this Fair Value: 32.8% versus the recent US$24.87 share price

Revenue growth assumption: 2.94% per year

  • Leans on premium Jack Daniel's flavors, a larger distributor footprint, and deeper reach in emerging markets to support higher revenue and margin potential than many models assume.
  • Factors in ESG credentials and ready to drink products as helpful for brand loyalty, pricing power, and earnings resilience.
  • Highlights risks such as health driven moderation, concentration in Jack Daniel's, cost inflation, and regulation, but assumes Brown-Forman can still reach higher earnings and a 22.5x P/E by 2029 on bullish forecasts.

Fair Value: US$21.00

Implied premium to this Fair Value: 18.4% versus the recent US$24.87 share price

Revenue growth assumption: 0.47% per year

  • Starts from slow expected category growth, more health conscious consumers, and heavier regulation that could pressure both volumes and margins over time.
  • Flags reliance on a small group of core brands and greater exposure to mature US and Western European markets as constraints on earnings and cash flow potential.
  • Assumes earnings in 2029 would justify a lower 14.7x P/E and a Fair Value around US$21.00, even after considering possible corporate interest and buyout speculation.

If you want to go a level deeper and see how your own assumptions compare with these bullish and bearish setups, you can review the full spread of Brown-Forman Narratives and plug in your own views on revenue, margins, and valuation to see where your number lands.

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Brown-Forman on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Do you think there's more to the story for Brown-Forman? Head over to our Community to see what others are saying!

NYSE:BF.B 1-Year Stock Price Chart
NYSE:BF.B 1-Year Stock Price Chart

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.